Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis
Mark Deneau(University of Utah), Tamir Miloh(University of California, San Francisco), Matthew DiGuglielmo(Alfred I. duPont Hospital for Children), Nitika Gupta(Children's Healthcare of Atlanta), Wael El‐Matary(University of Manitoba), Reham Abdou(University at Buffalo, State University of New York), Amanda Ricciuto(Hospital for Sick Children), Miriam B. Vos(Centers for Disease Control and Prevention), Mercedes Martínez(North West Armed Forces Hospital), Fateh Bazerbachi(St. Cloud Hospital), Raghu Varier(Yale University), Pamela L. Valentino(Yale University), Marcus Auth(University of Birmingham), Cara L. Mack(University of Colorado Denver), Frédèric Gottrand(Hôpital Jeanne de Flandre), Sirish Palle(Emory University), Kaija‐Leena Kolho(University of Helsinki), Federica Ferrari(Yale University), Raffaele Iorio(King's College Hospital), Bernadette Vitola(Medical College of Wisconsin), Marek Woynarowski(Yale University), Anastasia Konidari(University of Liverpool), Jason Yap(University of Alberta), Atsushi Tanaka(Teikyo University), Binita M. Kamath(Hospital for Sick Children), Bart G.P. Koot(Virginia Commonwealth University), Katryn N. Furuya(Alfred I. duPont Hospital for Children), Matjaž Homan(University of Ljubljana), Eyal Shteyer(Shaare Zedek Medical Center), Veena Venkat(University of Pittsburgh Medical Center), Vratislav Smolka(Yale University), Achiya Amir(Tel Aviv University), Kyung Mo Kim(Korea Institute of Drug Safety and Risk Management), Pushpa Sathya(Memorial University of Newfoundland), Alexandra Papadopoulou(National and Kapodistrian University of Athens), Parvathi Mohan(George Washington University), Mounif El‐Youssef(Mayo Clinic in Arizona), Lawrence J. Saubermann(University of Rochester Medical Center), M. Kyle Jensen(Primary Children's Hospital), Albert Chan(Queen Mary Hospital), A Broderick(University College Dublin), Mansi Amin(University of California, San Francisco)
Cited by 47
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents
|Journal of Pediatric Gastroenterology and Nutrition|2013|1.4k
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k